Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of combined measurement of serum bile acids and ferritin as additional prognostic markers to predict failure to reach sustained response to antiviral treatment in chronic hepatitis C.
Jorquera F, Monte MJ, Guerra J, Sanchez-Campos S, Merayo JA, Olcóz JL, González-Gallego J, Marin JJ. Jorquera F, et al. Among authors: olcoz jl. J Gastroenterol Hepatol. 2005 Apr;20(4):547-54. doi: 10.1111/j.1440-1746.2005.03725.x. J Gastroenterol Hepatol. 2005. PMID: 15836702
Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy.
Sáez-Royuela F, Linares P, Cervera LA, Almohalla C, Jorquera F, Lorenzo S, García I, Karpman G, Badia E, Vallecillo MA, Moncada A, Calvo S, Olcoz JL; Castile and Leon Hepatology Association (ACyLHE). Sáez-Royuela F, et al. Among authors: olcoz jl. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):305-12. doi: 10.1097/MEG.0000000000000533. Eur J Gastroenterol Hepatol. 2016. PMID: 26636405
Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C.
Lima-Cabello E, García-Mediavilla MV, Miquilena-Colina ME, Vargas-Castrillón J, Lozano-Rodríguez T, Fernández-Bermejo M, Olcoz JL, González-Gallego J, García-Monzón C, Sánchez-Campos S. Lima-Cabello E, et al. Among authors: olcoz jl. Clin Sci (Lond). 2011 Mar;120(6):239-50. doi: 10.1042/CS20100387. Clin Sci (Lond). 2011. PMID: 20929443
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.
Porras D, Nistal E, Martínez-Flórez S, Olcoz JL, Jover R, Jorquera F, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Porras D, et al. Among authors: olcoz jl. Mol Nutr Food Res. 2019 Apr;63(8):e1800930. doi: 10.1002/mnfr.201800930. Epub 2019 Feb 4. Mol Nutr Food Res. 2019. PMID: 30680920
Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice.
Crespo J, Cabezas J, Sacristán B, Olcoz JL, Pérez R, De la Vega J, García R, García-Pajares F, Sáez-Royuela F, González JM, Jiménez F, Rodríguez S, Cuadrado A, López-Arias MJ, García I, Milla A, García-Riesco E, Muñoz M, Sánchez-Antolín G, Jorquera F. Crespo J, et al. Among authors: olcoz jl. Liver Int. 2015 Feb;35(2):401-8. doi: 10.1111/liv.12536. Epub 2014 Apr 9. Liver Int. 2015. PMID: 24650000
44 results